Moderna Inc
Veridion Score
Composite trend over time
Why is MRNA moving today?
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
MRNA insider activity
Moderna Inc
2 insiders bought in the last 90 days
Net selling: -$4.5M across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-03 | 2026-06-01 | Mock James M | Insider | sell | $47.19 | 1,197 | 59,594 | $56K | SEC Form 4 |
| 2026-06-03 | 2026-06-01 | Klinger Shannon Thyme | Insider | sell | $47.19 | 1,047 | 67,468 | $49K | SEC Form 4 |
| 2026-06-03 | 2026-06-01 | Hoge Stephen | Insider | sell | $47.19 | 4,488 | 1,483,848 | $212K | SEC Form 4 |
| 2026-05-29 | 2026-05-28 | Mock James M | Insider | sell | $47.61 | 159 | 58,316 | $8K | SEC Form 4 |
| 2026-05-29 | 2026-05-28 | Klinger Shannon Thyme | Insider | sell | $47.61 | 159 | 66,350 | $8K | SEC Form 4 |
Showing 5 recent rows. Sovereign unlocks 60 additional rows, full sorting, and the named-filer history.
Upgrade to Sovereign · $25/moMRNA contract awards, year to date.
Public federal awards linked to this ticker.
FY26-27 PEDIATRIC COVID VACCINES EO 14398
FY26-27 ADULT COVID VACCINES EO 14398
MRNA lobbying filings, year to date.
Registered lobbying filings matched to Moderna Inc.